Evidence map›Paper›PMID 23885079›Full record

ArticleJournal of virology2013

Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors.

Chidananda Sulli, Soma S R Banik, Justin Schilling, Allan Moser, Xiaoxiao Xiang, Riley Payne, Antony Wanless, Sharon H Willis, Cheryl Paes, Joseph B Rucker and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Chidananda SulliIntegral Molecular, Inc., Philadelphia, Pennsylvania, USA.
Soma S R Banik
Justin Schilling
Allan Moser
Xiaoxiao Xiang
Riley Payne
Antony Wanless
Sharon H Willis
Cheryl Paes
Joseph B Rucker
Benjamin J Doranz
Integral Molecular (United States) · US

Funding

Treatments for Nipah Virus InfectionU54AI057159 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CLARDY, JON · 2003 to 2013
$113.7M
Ion Channel Assay for Identifying Influenza TherapeuticsR01AI071337 · NIAID · INTEGRAL MOLECULAR · PI DORANZ, BENJAMIN JACOB · 2006 to 2006
$845k
Identification of Novel Influenza InhibitorsR43AI079856 · NIAID · INTEGRAL MOLECULAR · PI DORANZ, BENJAMIN J · 2008 to 2009
$599k
Identification and Development of Novel Influenza M2 InhibitorsU01AI078500 · NIAID · INTEGRAL MOLECULAR · PI DORANZ, BENJAMIN J · 2009 to 2009
$500k
NIAID NIH HHS AI057159NIAID NIH HHS R01 AI071337NIAID NIH HHS R43 AI079856NIAID NIH HHS U01 AI078500NIAID NIH HHS U54 AI057159
6 · The paper itself

Abstract

The influenza virus M2 protein is a well-validated yet underexploited proton-selective ion channel essential for influenza virus infectivity. Because M2 is a toxic viral ion channel, existing M2 inhibitors have been discovered through live virus inhibition or medicinal chemistry rather than M2-targeted high-throughput screening (HTS), and direct measurement of its activity has been limited to live cells or reconstituted lipid bilayers. Here, we describe a cell-free ion channel assay in which M2 ion channels are incorporated into virus-like particles (VLPs) and proton conductance is measured directly across the viral lipid bilayer, detecting changes in membrane potential, ion permeability, and ion channel function. Using this approach in high-throughput screening of over 100,000 compounds, we identified 19 M2-specific inhibitors, including two novel chemical scaffolds that inhibit both M2 function and influenza virus infectivity. Counterscreening for nonspecific disruption of viral bilayer ion permeability also identified a broad-spectrum antiviral compound that acts by disrupting the integrity of the viral membrane. In addition to its application to M2 and potentially other ion channels, this technology enables direct measurement of the electrochemical and biophysical characteristics of viral membranes.

Indexed as

ProtonsAntiviral AgentsApoptosisCell MembraneHEK293 CellsHigh-Throughput Screening AssaysHumansHydrogen-Ion ConcentrationInfluenza A virusInfluenza, HumanIon ChannelsLipid BilayersSmall Molecule LibrariesViral Matrix ProteinsVirionViroporin ProteinsAntiviral AgentsIon ChannelsLipid BilayersM2 protein, Influenza A virusProtonsSmall Molecule LibrariesViral Matrix ProteinsViroporin Proteins

Identifiers

PMID23885079
PMCPMC3807417
OpenAlexW1980228427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.